RA Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306M Hold
9,550,191
3.24% 7
2025
Q4
$335M Sell
9,550,191
-588,747
-6% -$21.4M 3.43% 7
2025
Q3
$288M Hold
10,138,938
3.55% 8
2025
Q2
$184M Hold
10,138,938
3.09% 9
2025
Q1
$208M Buy
10,138,938
+1,293,938
+15% +$28.8M 3.47% 5
2024
Q4
$227M Buy
8,845,000
+781,000
+10% +$16.6M 3.03% 7
2024
Q3
$134M Hold
8,064,000
1.54% 21
2024
Q2
$155M Buy
8,064,000
+200,000
+3% +$4.01M 2.05% 16
2024
Q1
$186M Hold
7,864,000
2.37% 8
2023
Q4
$87.8M Sell
7,864,000
-1,136,000
-13% -$10.4M 1.37% 21
2023
Q3
$83.3M Hold
9,000,000
1.64% 19
2023
Q2
$107M Buy
9,000,000
+5,000,000
+125% +$66.3M 2.02% 11
2023
Q1
$53M Hold
4,000,000
1.2% 27
2022
Q4
$43.6M Buy
+4,000,000
New +$39.8M 0.88% 35

Other funds holding NAMS